Less than 1% of all dollars spent on health research are invested in pain research. It is up to us to ensure that the treatments of today are not those of tomorrow. Every donated dollar invested in CRPS and RSD research will help fund studies for better treatment and a cure.
Presently we are funding five ongoing CRPS and RSD research projects:
- Autoimmune Determinants of Complex Regional Pain Syndrome (CRPS) submitted by Dr. David J. Clark, Stanford & Palo Alto Veterans Institute for Research ($129,093).
- Nitrous Oxide for the Treatment of Complex Regional Pain Syndrome: A Prospective Randomized Controlled Pilot Study ($121,734) submitted by Dr. Hale, Cleveland Clinic Foundation.
- Pain – a role for cross-talk between skin fibroblasts and the nociceptive system in skin of patients with Complex Regional Pain Syndrome (CRPS)” ($235 880) submitted by PD Dr. Astrid Jüngel and Prof. Dr. med. et Dr. phil. Florian Brunner, Balgrist University Hospital and University Hospital Zurich
- Begun the analysis of RSDSA’s 10-study of how CRPS impacts the long-term health of people with CRPS, and;
- a pilot study to treat CRPS with low dose naltrexone ($194,955) submitted by Sean Mackey at Stanford University
Please bookmark this page and return for updates, or subscribe to our blog and newsletter to receive the latest information automatically. To help us continue our research funding efforts we encourage you to contribute today. Here are three reasons to invest in CRPS and RSD research: